Recalls / Active ingredient / Loratadine
Loratadine
6 FDA drug recalls involving the active ingredient “Loratadine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-10-12 | Class III | AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2021-10-12 | Class III | Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 1 | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2021-03-15 | Class II | Children's Loratadine Oral Solution USP, 5 mg/5 mL (Antihistamine) Allergy Grape Flavor 4 FL OZ (120 mL) NDC 5 | Cardinal Health Inc. |
| 2015-07-28 | Class III | Ohm Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets, Distributed by Ohm Laboratories, I | Ohm Laboratories, Inc. |
| 2014-12-30 | Class II | Children's Loratadine Syrup (Loratadine Oral Solution) 5 mg/5 mL, Antihistamine, Grape Flavored Syrup, 24 Hour | Taro Pharmaceuticals U.S.A., Inc. |
| 2014-02-07 | Class II | Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg , Lorata | Ohm Laboratories, Inc. |